The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Are three drugs better than two and does docetaxel trump paclitaxel in induction therapy for locally advanced oral cavity cancers?
Vanita Noronha
No relevant relationships to disclose
Vijay Patil
No relevant relationships to disclose
Amit Joshi
No relevant relationships to disclose
S Juvekar
No relevant relationships to disclose
Bharatsinha Baburao Bhosale
No relevant relationships to disclose
Bhavesh Poladia
No relevant relationships to disclose
Sushmita Rath
No relevant relationships to disclose
Pankaj Chaturvedi
No relevant relationships to disclose
D. Chaukar
No relevant relationships to disclose
P. S. Pai
No relevant relationships to disclose
A. K. Dcruz
No relevant relationships to disclose
Kumar Prabhash
No relevant relationships to disclose